Welcome Purposeful: drug repurposing with a focus on rare diseases
- Posted by Metavallon VC Team
- On October 4, 2018
- No tags found
We are delighted to welcome Athens-based Purposeful as the latest addition to our investment portfolio. Using its advanced computational workflow and chemo/bioinformatics expertise, Purposeful aims to discover alternative effects for drugs already on the market. The company has developed a smart filtering strategy, which in combination with its focus on the overlooked rare disease area […]
Read More



